Abstract
Introduction
Becker muscular dystrophy (BMD) is a genetic and progressive neuromuscular disease caused by mutations in the dystrophin gene with no available cure. A case report and comprehensive review of BMD cases aim to provide important clues for early diagnosis and implications for clinical practice. Genes and pathways identified from microarray data of muscle samples from patients with BMD help uncover the potential mechanism and provide novel therapeutic targets for dystrophin-deficient muscular dystrophies.
Methods
We describe a BMD family with a 10-year-old boy as the proband and reviewed BMD cases from PubMed. Datasets from the Gene Expression Omnibus database were downloaded and integrated with the online software.
Results
The systematic review revealed the clinical manifestations and mutation points of the dystrophin gene. Gene ontology analysis showed that extracellular matrix organization and extracellular structure organization with enrichment of upregulated genes coexist in three datasets. We present the first report of TUBA1A involvement in the development of BMD/Duchenne muscular dystrophy (DMD).
Discussion
This study provides important implications for clinical practice, uncovering the potential mechanism of the progress of BMD/DMD, and provided new therapeutic targets.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10072-021-05499-2/MediaObjects/10072_2021_5499_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10072-021-05499-2/MediaObjects/10072_2021_5499_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10072-021-05499-2/MediaObjects/10072_2021_5499_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10072-021-05499-2/MediaObjects/10072_2021_5499_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10072-021-05499-2/MediaObjects/10072_2021_5499_Fig5_HTML.png)
Similar content being viewed by others
References
Guo R, Zhu G, Zhu H, Ma R, Peng Y, Liang D et al (2015) DMD mutation spectrum analysis in 613 Chinese patients with dystrophinopathy. J Hum Genet 60:435–442. https://doi.org/10.1038/jhg.2015.43
Sato T, Higashioka K, Sakurai H, Yamamoto T, Goshima N, Ueno M et al (2019) Core transcription factors promote induction of PAX3-positive skeletal muscle stem cells. Stem Cell Rep 13:352–365. https://doi.org/10.1016/j.stemcr.2019.06.006
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. https://doi.org/10.1016/S1474-4422(09)70271-6
El-Aloul B, Altamirano-Diaz L, Zapata-Aldana E, Rodrigues R, Malvankar-Mehta MS, Nguyen CT et al (2017) Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: a systematic review. Neuromuscul Disord 27:4–14. https://doi.org/10.1016/j.nmd.2016.09.019
Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N (2014) A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 24:482–491. https://doi.org/10.1016/j.nmd.2014.03.008
Tsoumpra MK, Fukumoto S, Matsumoto T, Takeda S, Wood MJA, Aoki Y. 2019 Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases. EBiomedicine;45: 630–645. https://doi.org/10.1016/j.ebiom.2019.06.036
Wang DN, Wang ZQ, Yan L, He J, Lin MT, Chen WJ et al (2017) Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China. Neuromuscul Disord 27:715–722. https://doi.org/10.1016/j.nmd.2017.02.010
Bell JM, Shields MD, Watters J, Hamilton A, Beringer T, Elliott M, et al. 2017 Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy. Cochrane Database Syst Rev;1: CD010899. https://doi.org/10.1002/14651858.CD010899.pub2
Salmaninejad A, Jafari Abarghan Y, Bozorg Qomi S, Bayat H, Yousefi M, Azhdari S et al (2020) Common therapeutic advances for Duchenne muscular dystrophy (DMD). Int J Neurosci 131(14):370–389. https://doi.org/10.1080/00207454.2020.1740218
Acsadi G, Moore SA, Chéron A, Delalande O, Bennett L, Kupsky W et al (2012) Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy. J Biol Chem 287:18153–18162. https://doi.org/10.1074/jbc.M111.284521
Andrikopoulos G, Kourouklis S, Trika C, Tzeis S, Rassias I, Papademetriou C et al (2013) Cardiac resynchronization therapy in Becker muscular dystrophy. Hellenic J Cardiol 54:227–229
Banihani R, Baskin B, Halliday W, Kobayashi J, Kawamura A, McAdam L et al (2016) A novel mutation in DMD (c.1079715G.A) causes Becker muscular dystrophy associated with intellectual disability. J Dev Behav Pediatr 37(3):239–244. https://doi.org/10.1097/DBP.0000000000000262
Calcaterra V, Malvezzi A, Toglia R, Berardinelli A, Bozzola E, Bozzola M, et al. 2013 Growth hormone deficiency in a patient with Becker muscular dystrophy: a pediatric case report. Case Rep Endocrinol 684249 2013. https://doi.org/10.1155/2013/684249
Cao JQ, Zhang C, Feng SW, Yang J, Li Z, Zhang M et al (2011) Study of dystrophin gene non-deletion/duplication mutations causing Becker muscular dystrophy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 28:308–312. https://doi.org/10.3760/cma.j.issn.1003-9406.2011.03.016
Chamberlain RC, Smith EC, Campbell MJ (2015) Novel rod domain duplication in dystrophin resulting in X-linked dilated cardiomyopathy. Pediatr Neurol 53:439–441. https://doi.org/10.1016/j.pediatrneurol.2015.07.008
Dinopoulos A, Papadopoulou A, Manta P, Kekou K, Kanelopoulos T, Fretzayas A et al (2010) Coinheritance of Noonan syndrome and Becker muscular dystrophy. Neuromuscul Disord 20:61–63. https://doi.org/10.1016/j.nmd.2009.08.008
Ferreiro V, Giliberto F, Muñiz GM, Francipane L, Marzese DM, Mampel A et al (2009) Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion. Muscle Nerve 39:239–243. https://doi.org/10.1002/mus.21193
Finsterer J, Stöllberger C, Berger E (2012) Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy. Herz 37:702–705. https://doi.org/10.1007/s00059-012-3643-8
Flanigan KM, Dunn D, Larsen CA, Medne L, Bönnemann CB, Weiss RB (2011) Becker muscular dystrophy due to an inversion of exons 23 and 24 of the DMD gene. Muscle Nerve 44:822–825. https://doi.org/10.1002/mus.22226
Fujii K, Minami N, Hayashi Y, Nishino I, Nonaka I, Tanabe Y et al (2009) Homozygous female Becker muscular dystrophy. Am J Med Genet A 149A(5):1052–1055. https://doi.org/10.1002/ajmg.a.32808
Guo X, Dai Y, Cui L, Fang Q (2014) A novel dystrophin deletion mutation in a Becker muscular dystrophy patient with early-onset dilated cardiomyopathy. Can J Cardiol 30(956):e1-956.e3. https://doi.org/10.1016/j.cjca.2014.05.002
Gurvich OL, Tuohy TM, Howard MT, Finkel RS, Medne L, Anderson CB et al (2008) DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy. Ann Neurol 63:81–89. https://doi.org/10.1002/ana.21290
Hamzi K, Ben Itto AB, Itri M, Nadifi S (2014) Prenatal diagnosis of BMD in Morocco: evolution and limits. J Mol Neurosci 52:459–460. https://doi.org/10.1007/s12031-013-0106-5
Helderman-van den Enden ATJM, Straathof CSM, Aartsma-Rus A, den Dunnen JT, Verbist BM, Bakker E et al (2010) Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients. Neuromuscul Disord 20(4):251–254. https://doi.org/10.1016/j.nmd.2010.01.013
Hollander SA, Rizzuto S, Hollander AM, Lin A, Liu E, Murray JM et al (2016) Obesity and premature loss of mobility in two adolescents with Becker muscular dystrophy after heartmate II Implantation. ASAIO J 62(1):e5–e7. https://doi.org/10.1097/MAT.0000000000000292
Lee KA, Han SH, Choi JR, Chung JS, Choi YC (2008) Becker muscular dystrophy with r(X) carrying an out-of-frame DMD deletion. Pediatr Neurol 39:129–132. https://doi.org/10.1016/j.pediatrneurol.2008.05.002
Lerario A, Colombo I, Milani D, Peverelli L, Villa L, Del Bo R et al (2016) A case report with the peculiar concomitance of 2 different genetic syndromes. Medicene (United States) 95(49):e5567. https://doi.org/10.1097/MD.0000000000005567
Messina MF, Aguennouz M, Arrigo T, Rodolico C, Valenzise M, Musumeci O et al (2008) Novel SHOX gene mutation in a short boy with Becker muscular dystrophy: double trouble in two adjacent genes. Horm Res 69:124–128. https://doi.org/10.1159/000111816
Miao J, Feng JC, Zhu D, Yu XF. 2016 A case report: Becker muscular dystrophy presenting with epilepsy and dysgnosia induced by duplication mutation of dystrophin gene. BMC Neurol;16: 255. https://doi.org/10.1186/s12883-016-0777-y
Nakamura M, Sunagawa O, Hokama R, Tsuchiya H, Miyara T, Taba Y et al (2016) A case of refractory heart failure in Becker muscular dystrophy improved with corticosteroid therapy. Int Heart J 57(5):640–644. https://doi.org/10.1536/ihj.16-044
Poole TC, Lim TYJ, Buck J, Kong AS (2010) Perioperative cardiac arrest in a patient with previously undiagnosed Becker’s muscular dystrophy after isoflurane anaesthesia for elective surgery. Br J Anaesth 104:487–489. https://doi.org/10.1093/bja/aeq035
Renard D, Labauge P (2010) Thenar and hypothenar muscle hypertrophy in Becker muscular dystrophy. Neuromuscul Disord 20(4):281. https://doi.org/10.1016/j.nmd.2010.01.004
Roque JM, Carvalho VO, Pascoalino LN, Ferreira SA, Bocchi EA, Guimarães GV (2011) Physical training in Becker muscular dystrophy associated with heart failure. Arq Bras Cardiol 97:e128–e131. https://doi.org/10.1590/S0066-782X2011001500016
Rudnik-Schöneborn S, Weis J, Kress W, Häusler M, Zerres K (2008) Becker’s muscular dystrophy aggravating facioscapulohumeral muscular dystrophy - double trouble as an explanation for an atypical phenotype. Neuromuscul Disord 18:881–885. https://doi.org/10.1016/j.nmd.2008.06.387
Shaboodien G, Watkins DA, Pillay K, Beighton P, Heckmann JM, Mayosi BM (2015) Limb-girdle weakness in a marfanoid man: distinguishing calpainopathy from Becker’s muscular dystrophy. Pract Neurol 15:152–154. https://doi.org/10.1136/practneurol-2014-000992
Sharma A, Sane H, Gokulchandra N, Sharan R, Paranjape A, Kulkarni P et al (2016) Effect of cellular therapy in progression of Becker’s muscular dystrophy: a case study. Eur J Transl Myol 26(1):5522. https://doi.org/10.4081/ejtm.2016.5522
Silva Vieira M, Drivas P, Mohiaddin RH (2012) Becker’s muscular dystrophy cardiomyopathy: insights from imaging modalities. Rev Port Cardiol 31:833–834. https://doi.org/10.1016/j.repc.2012.05.011
Tramonti C, Rossi B, Chisari C (2016) Extensive functional evaluations to monitor aerobic training in Becker muscular dystrophy: a case report. Eur J Transl Myol 26(2):5873. https://doi.org/10.4081/ejtm.2016.5873
Tsuda T, Fitzgerald K, Scavena M, Gidding S, Cox MO, Marks H et al (2015) Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27. J Hum Genet 60:151–155. https://doi.org/10.1038/jhg.2014.112
Webb ST, Patil V, Vuylsteke A (2007) Anaesthesia for non-cardiac surgery in a patient with Becker’s muscular dystrophy supported with a left ventricular assist device (1). Eur J Anaesthesiol. https://doi.org/10.1017/S0265021507000336
Witting N, Duno M, Vissing J (2011) Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype. Acta Myol 30:182–184
Witting N, Duno M, Vissing J (2013) Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2. Neuromuscul Disord 23:25–28. https://doi.org/10.1016/j.nmd.2012.07.004
Yilmaz A, Gdynia HJ, Mahrholdt H, Sechtem U (2009) Cardiovascular magnetic resonance reveals similar damage to the heart of patients with Becker and limb-girdle muscular dystrophy but no cardiac symptoms. J Magn Reson Imaging 30:876–877. https://doi.org/10.1002/jmri.21905
Rha DW, Park ES, Kim J, Kim SH, Chang WH (2009) Detection of focal cerebral injury using diffusion tensor magnetic resonance imaging in a boy with Becker muscular dystrophy. Neuropediatrics 40:298–300. https://doi.org/10.1055/s-0030-1252050
Ionescu CN, Kapoor A, Protopapas Z, Marcu CB (2009) Cardiac assessment of patients with Becker’s muscular dystrophy. Conn Med 73:395–397
Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS et al (2002) Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A 99(23):15000–15005. https://doi.org/10.1073/pnas.192571199
Haslett JN, Sanoudou D, Kho AT, Han M, Bennett RR, Kohane IS et al (2003) Gene expression profiling of Duchenne muscular dystrophy skeletal muscle. Neurogenetics 4:163–171. https://doi.org/10.1007/s10048-003-0148-x
Pescatori M, Broccolini A, Minetti C, Bertini E, Bruno C, D’Amico A et al (2007) Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J 21(4):1210–1226. https://doi.org/10.1096/fj.06-7285com
Barakat-Haddad C, Shin S, Candundo H, Van Lieshout PV, Martino R (2017) A systematic review of risk factors associated with muscular dystrophies. Neurotoxicology 61:55–62. https://doi.org/10.1016/j.neuro.2016.03.007
Aartsma-Rus A, den Dunnen JT (2019) Phenotype predictions for exon deletions/duplications: a user guide for professionals and clinicians using Becker and Duchenne muscular dystrophy as examples. Hum Mutat 40:1–4. https://doi.org/10.1002/humu.23850
Salmaninejad A, Valilou SF, Bayat H, Ebadi N, Daraei A, Yousefi M et al (2018) Duchenne muscular dystrophy: an updated review of common available therapies. Int J Neurosci 128:854–864. https://doi.org/10.1080/00207454.2018.1430694
Acknowledgements
We thank the patients for their cooperation. We wish to thank Dr. Xiaoqin Hu, MD, Ph.D., who helped contact the patients.
We are grateful to Professor Cheng Zhang at the Department of Neurology, Affiliated Hospital for Sun-Yat-sen University, China, for the thoughtful discussion and clinical evaluation of patients.
Funding
This work was supported by the National Natural Science Foundation of China grants (No.81550031 and No.81201981), Hubei Provincial Health and Family Planning Commission Key Support Project (No. WJ2017Z025), Hubei Provincial Natural Science Foundation Surface project grant (No.2015CFB197), and Talents Innovation, Entrepreneurship, and Excellence-creating Project grant of Yichang City, Hubei Province.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, M., Han, Y., Wang, S. et al. Becker muscular dystrophy: case report, review of the literature, and analysis of differentially expressed hub genes. Neurol Sci 43, 243–253 (2022). https://doi.org/10.1007/s10072-021-05499-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05499-2